Advanced Medical Solutions Group (LON:AMS) Stock Price Up 17.8% – What’s Next?

Advanced Medical Solutions Group plc (LON:AMS)’s stock price shot up 17.8% on Tuesday . The stock traded as high as GBX 272 and last traded at GBX 261.52. 4,907,500 shares changed hands during trading, an increase of 250% from the average session volume of 1,401,292 shares. The stock had previously closed at GBX 222.

Analyst Ratings Changes

Several research firms have recently weighed in on AMS. Berenberg Bank reaffirmed a “buy” rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a report on Wednesday, March 18th. Royal Bank Of Canada reissued a “sector perform” rating and issued a GBX 260 price target on shares of Advanced Medical Solutions Group in a research note on Thursday, April 9th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of GBX 270.25.

Advanced Medical Solutions Group Stock Down 1.5%

The business’s 50 day moving average is GBX 205.70 and its 200-day moving average is GBX 213.20. The stock has a market cap of £564.81 million, a price-to-earnings ratio of 57.74, a PEG ratio of 5.00 and a beta of 0.63. The company has a debt-to-equity ratio of 31.50, a quick ratio of 4.58 and a current ratio of 2.79.

Advanced Medical Solutions Group (LON:AMS) last released its quarterly earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a net margin of 4.35% and a return on equity of 3.87%. On average, sell-side analysts predict that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.